The Hypophosphatasia (HPP) is a rare genetic disease caused by mutations in the ALPL gene. It is a metabolic disorder that effects multiple body systems and leads to life-threatening complications. This disease leads to abnormal development of the bones due to defective bone mineralization and can lead to rickets, tempering of the bones that result in different types of bone abnormalities. The sign and symptoms include soft bones, hypercalcemia, short stature and weak bones with loss of ... Read more
The report "Infantile and Juvenile-onset Hypophosphatasia Treatment Market - Global Industry Trend Analysis 2012 to 2016 and Forecast 2016 - 2025" gives complete assessment of the latest trends, challenges of market.
The objectives of this study are as follows:
To define, describe, and forecast the "Infantile and Juvenile-onset Hypophosphatasia Treatment" market by type, application,
